Husain S Ali, Shah Vaqar, Alvarado Verduzco Hector, King Kristen L, Brennan Corey, Batal Ibrahim, Coley Shana M, Hall Isaac E, Stokes M Barry, Dube Geoffrey K, Crew R John, Perotte Adler, Natarajan Karthik, Carpenter Dustin, Sandoval P Rodrigo, Santoriello Dominick, D'Agati Vivette, Cohen David J, Ratner Lloyd, Markowitz Glen, Mohan Sumit
Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, New York, USA.
The Columbia University Renal Epidemiology (CURE) Group, New York, New York, USA.
Kidney Int Rep. 2020 Aug 14;5(11):1906-1913. doi: 10.1016/j.ekir.2020.08.004. eCollection 2020 Nov.
The factors that influence deceased donor kidney procurement biopsy reliability are not well established. We examined the impact of biopsy technique and pathologist training on procurement biopsy accuracy.
We retrospectively identified all deceased donor kidney-only transplants at our center from 2006 to 2016 with both procurement and reperfusion biopsies performed and information available on procurement biopsy technique and pathologist (n = 392). Biopsies were scored using a previously validated system, classifying "suboptimal" histology as the presence of at least 1 of the following: glomerulosclerosis ≥11%, moderate/severe interstitial fibrosis/tubular atrophy, or moderate/severe vascular disease. We calculated relative risk ratios (RRR) to determine the influence of technique (core vs. wedge) and pathologist (renal vs. nonrenal) on concordance between procurement and reperfusion biopsy histologic classification.
A total of 171 (44%) procurement biopsies used wedge technique, and 221 (56%) used core technique. Results of only 36 biopsies (9%) were interpreted by renal pathologists. Correlation between procurement and reperfusion glomerulosclerosis was poor for both wedge ( = 0.11) and core ( = 0.14) biopsies. Overall, 34% of kidneys had discordant classification on procurement versus reperfusion biopsy. Neither biopsy technique nor pathologist training was associated with concordance between procurement and reperfusion histology, but a larger number of sampled glomeruli was associated with a higher likelihood of concordance (adjusted RRR = 1.12 per 10 glomeruli, 95% confidence interval = 1.04-1.22).
Biopsy technique and pathologist training were not associated with procurement biopsy histologic accuracy in this retrospective study. Prospective trials are needed to determine how to optimize procurement biopsy practices.
影响已故供体肾获取活检可靠性的因素尚未完全明确。我们研究了活检技术和病理科医生培训对获取活检准确性的影响。
我们回顾性分析了2006年至2016年在本中心进行的所有仅涉及已故供体肾的移植手术,这些手术均进行了获取活检和再灌注活检,且有关于获取活检技术和病理科医生的可用信息(n = 392)。活检采用先前验证的系统进行评分,将“次优”组织学定义为存在以下至少一项:肾小球硬化≥11%、中度/重度间质纤维化/肾小管萎缩或中度/重度血管疾病。我们计算相对风险比(RRR),以确定技术(芯针活检与楔形活检)和病理科医生(肾脏病理医生与非肾脏病理医生)对获取活检和再灌注活检组织学分类一致性的影响。
共有171例(44%)获取活检采用楔形技术,221例(56%)采用芯针活检技术。只有36例活检(9%)由肾脏病理医生解读。楔形活检( = 0.11)和芯针活检( = 0.14)的获取活检与再灌注活检的肾小球硬化之间的相关性均较差。总体而言,34%的肾脏在获取活检与再灌注活检时分类不一致。活检技术和病理科医生培训均与获取活检和再灌注组织学的一致性无关,但更多的肾小球采样与更高的一致性可能性相关(调整后的RRR = 每10个肾小球为1.12,95%置信区间 = 1.04 - 1.22)。
在这项回顾性研究中,活检技术和病理科医生培训与获取活检的组织学准确性无关。需要进行前瞻性试验以确定如何优化获取活检操作。